Genzyme Dropping Because of FDA Warning (GENZ)
By Benzinga Staff
November 13, 2009 11:52 AM
November 13, 2009 11:52 AM
The US FDA is warning doctors about potential for foreign particle contamination of several rare drug diseases manufactured by Genzyme (Nasdaq: GENZ).
Genzyme is trading down 7.5% to $49.18.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
